The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 29 million people and has caused more than 900,000 deaths worldwide as of September 14, 2020. The SARS-CoV-2 human cell receptor ACE2 has recently received extensive attention for its role in SARS-CoV-2 infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhilan, Li, Lin, Li, Mengyuan, Wang, Xiaosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462778/
https://www.ncbi.nlm.nih.gov/pubmed/32905022
http://dx.doi.org/10.1016/j.csbj.2020.08.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462778/
https://www.ncbi.nlm.nih.gov/pubmed/32905022
http://dx.doi.org/10.1016/j.csbj.2020.08.024

Ejemplares similares